Huhtamaki Oyj:企業のM&A・事業提携・投資動向

◆英語タイトル:Huhtamaki Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1915
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Huhtamaki Oyj – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Huhtamaki Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Huhtamaki Oyj since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Huhtamaki Oyj’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Huhtamaki Oyj. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Huhtamaki Oyj’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Huhtamaki Oyj and its subsidiaries since 2007.
- Information about key financial and legal advisors for Huhtamaki Oyj’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Huhtamaki Oyj’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 33
Partnership – Overview 33
Partnership – Deal reports 34
CAPITAL RAISING 36
Capital Raising – Overview 36
Capital Raising – Deal reports 37
DIVESTMENTS 40
Divestments – Overview 40
Divestments – Deal reports 41
APPENDIX 61
Contact Us 61
About MarketLine Financial Deals Database 61
Deal Definition and Methodology 63
About MarketLine 70

List of Tables
Table 1: Huhtamaki Oyj M&A volume and value trend (2014-YTD2018)
Table 2: Huhtamaki Oyj M&A activity by geography (2014-YTD2018)
Table 3: Huhtamaki Oyj partnership volume and value trend (2014-YTD2018)
Table 4: Huhtamaki Oyj partnership trend by key deal type (2014-YTD2018)
Table 5: Huhtamaki Oyj capital raising volume and value trend (2014-YTD2018)
Table 6: Huhtamaki Oyj capital raising by deal type (2014-YTD2018)
Table 7: Huhtamaki Oyj divestments volume and value trend (2014-YTD2018)
Table 8: Huhtamaki Oyj divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Huhtamaki Oyj M&A volume and value trend (2014-YTD2018)
Figure 2: Huhtamaki Oyj M&A activity by geography (2014-YTD2018)
Figure 3: Huhtamaki Oyj partnership volume and value trend (2014-YTD2018)
Figure 4: Huhtamaki Oyj partnership trend by key deal type (2014-YTD2018)
Figure 5: Huhtamaki Oyj capital raising volume and value trend (2014-YTD2018)
Figure 6: Huhtamaki Oyj capital raising by deal type (2014-YTD2018)
Figure 7: Huhtamaki Oyj divestments volume and value trend (2014-YTD2018)
Figure 8: Huhtamaki Oyj divestments by geography (2014-YTD2018)

★海外企業調査レポート[Huhtamaki Oyj:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Span-America Medical Systems Inc (SPAN):企業の財務・戦略的SWOT分析
    Summary Span-America Medical Systems Inc (Span-America), a subsidiary of Savaria Corp, is a medical device company that designs and manufactures pressure management and patient positioning products. The company offers products such as surfaces, seat cushions, patient positioners, skin care products, …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • OCON Medical Ltd:企業の製品パイプライン分析2018
    Summary OCON Medical Ltd (OCON Medical) is a manufacturer of women’s health products. The company provides leverages intrauterine technology to develop contraceptive intrauterine devices for women. It develops IUB SCu300, an advanced intrauterine device that is compatible with the uterine cavity. OC …
  • Liberty Holdings Ltd:戦略・SWOT・企業財務分析
    Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cegedim SA (CGM):企業の財務・戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is a technology company that offers healthcare technical services. The company offers solutions to facilitate business and medical operations. It offers health and preventive health management software used in management of individual and collective health and preventive …
  • Heron Resources Ltd:企業の戦略・SWOT・財務情報
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Portland General Electric Company:企業の戦略・SWOT・財務分析
    Portland General Electric Company - Strategy, SWOT and Corporate Finance Report Summary Portland General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Asiana Airlines Inc.:企業の戦略・SWOT・財務分析
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Immucor, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to …
  • Diasome Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Diasome Pharmaceuticals Inc (Diasome) is a pharmaceutical company that focusses on clinical and commercial development of therapies for diabetes and obesity. The company offers products in the fields of cell receptor targeting, insulin replacement, and hepatic (liver) glucose metabolism. Its …
  • Emsland Group:企業の戦略・SWOT・財務情報
    Emsland Group - Strategy, SWOT and Corporate Finance Report Summary Emsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Albertsons Companies, Inc.:戦略・SWOT・企業財務分析
    Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • HSBC Trinkaus & Burkhardt Private Banking:企業の戦略・SWOT・財務情報
    HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Nymox Pharmaceutical Corp (NYMX):企業の財務・戦略的SWOT分析
    Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Trina Solar Co Ltd:企業の戦略的SWOT分析
    Trina Solar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Ineos Group AG:石油・ガス:M&Aディール及び事業提携情報
    Summary Ineos Group AG (Ineos), a subsidiary of INEOS Group Holdings SA, is a chemical manufacturing company. It manufactures and sells petrochemicals, specialty chemicals and oil products. The company’s products include ammonia, nitric acid, sea salt, esters, bio fuel, sulphuric acid, amino resin, …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia) is an agricultural and clean technology company that develops and commercializes agricultural products. Its major products include goodwheat branded ingredients, nutritional oils, animal nutrition and agricultural products. The company's products exhibit tra …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nymox Pharmaceutical Corp (NYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆